Background: For more than a century, numerous medical researchers have attempted to discover remedies for viral illnesses. Unfortunately, except for vaccination, no safe and efficient cure has been discovered. There is still no effective treatment for acute viral infections. Marecipe AV therapeutics, a prescription compound of various herbs, has been utilized at our clinic for many years in the treatment of viral infectious diseases and has shown therapeutic effects. In order to obtain clear evidence of efficacy a series of experimental treatments with Marecipe AV has been conducted on animals with lethal viral infectious diseases.
Methods: The oral administration of Marecipe AV has been used to
treat several naturally infected viral infections with high morbidity and
mortality in animals. The efficacy was measured by comparing mortality rates
between treated and untreated animals. An analysis of variance was performed on
each data set. The Tukey-Kramer multiple comparisons test was utilized for comparisons
of death between treatment groups. Statistics were performed with the
Statistical Package for the Social Sciences (SPSS) version 24 for Windows.
Results: The mortality was 28.57% versus 100% among treated and untreated naturally infected pigs
with ASF. The mortality was 0% versus 100%
for treated and untreated cases when treatment was administered in the early
presymptomatic stage.
The mortality was 39.04% versus
100% in treated and untreated naturally infected ducks with Avian
influenza, and 0.86% versus 99.83%
for treated and untreated ducks when treatment is given in the early
presymptomatic stage. For chickens, the mortality was 4.60% versus 85% for treated and untreated,
respectively. All surviving ducks and chickens ultimately achieved complete recovery.
For dogs with canine distemper and/or canine parvovirus, the
mortality was 10.11% and 82.88% among the treated and untreated. For dogs
infected with parvovirus only, the mortality was 0% for treated and 87.5% for
untreated. Among dogs simultaneously infected with parvovirus and canine
distemper, the mortality was 15.25% and 96.84% for treated and untreated,
respectively. All surviving dogs fully recovered.
Conclusions: The findings indicate that Marecipe AV can save lives
from several deadly viral infections and cure these viral infections. Marecipe
AV therapeutics presents a new effective treatment Opportunity for acute viral
infections. Further research is needed to fully understand its mechanisms and
confirm its effectiveness through well-designed clinical trials.
Author
(s) Details
Jiangnan Feng
Department of Medicine, Tongrun Tang Traditional Chinese Medicine Clinic,
Nanchong City, Sichuan, China.
Zhenghua Ma
Department of Medicine, Tongrun Tang Traditional Chinese Medicine Clinic,
Nanchong City, Sichuan, China.
Hua Wu
Department of Medicine, Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, Wuhan, Hubei, China.
Chengsheng Yi
Department of Medicine, Tongrun Tang Traditional Chinese Medicine Clinic,
Nanchong City, Sichuan, China.
Meiying Gao
Department of Medicine, Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, Wuhan, Hubei, China.
Dengbin Zhu
Department of Medicine, Tongrun Tang Traditional Chinese Medicine Clinic,
Nanchong City, Sichuan, China.
Minghai Ma
Department of Medicine, Tongrun Tang Traditional Chinese Medicine Clinic,
Nanchong City, Sichuan, China.
Rui Cheng
Department of Medicine, Taipei Branch of Rui Peng Pet Hospital / Linjiang
Branch of Kedao Animal Hospital, Wuhan, Hubei, China.
Xia Liua
Department of Medicine, Tongrun Tang Traditional Chinese Medicine Clinic,
Nanchong City, Sichuan, China.
Xue Feng
Department of Medicine, Tongrun Tang Traditional Chinese Medicine Clinic,
Nanchong City, Sichuan, China.
Xianfu Li
Department of Medicine, Zhongde Institute of Psychology, Wuhan, Hubei,
China.
Yu Yan
Department of Medicine, Tongrun Tang Traditional Chinese Medicine Clinic,
Nanchong City, Sichuan, China.
Please see the book here:- https://doi.org/10.9734/bpi/crpbs/v5/2814
No comments:
Post a Comment